Report Detail
Global CRISPR Gene Testing and Diagnostics Market Growth (Status and Outlook) 2022-2028
- RnM4486345 |
- 25 August, 2022 |
- Global |
- 122 Pages |
- LPI(LP Information) |
- Other
The global market for CRISPR Gene Testing and Diagnostics is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC CRISPR Gene Testing and Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States CRISPR Gene Testing and Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe CRISPR Gene Testing and Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China CRISPR Gene Testing and Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key CRISPR Gene Testing and Diagnostics players cover 10x Genomics, Aelian Biotechnology, Agilent Technologies, Axxam and Beckman Coulter, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global CRISPR Gene Testing and Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global CRISPR Gene Testing and Diagnostics market, with both quantitative and qualitative data, to help readers understand how the CRISPR Gene Testing and Diagnostics market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the CRISPR Gene Testing and Diagnostics market and forecasts the market size by Type (Animals, Plants and Pathogens), by Application (Medical Industry, Agriculture and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Animals
Plants
Pathogens
Others
Segmentation by application
Medical Industry
Agriculture
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
10x Genomics
Aelian Biotechnology
Agilent Technologies
Axxam
Beckman Coulter
Becton, Dickinson and Company
Binx Health
bioMérieux
Bio-Rad Laboratories
Caspr Biotech
ERS Genomics
FASMAC
Illumina
Janssen Diagnostics
Locus Biosciences
Mammoth Biosciences
NRGene
Roche
Sherlock Biosciences
Thermo Fisher Scientific
Vivlion
Chapter Introduction
Chapter 1: Scope of CRISPR Gene Testing and Diagnostics, Research Methodology, etc.
Chapter 2: Executive Summary, global CRISPR Gene Testing and Diagnostics market size and CAGR, CRISPR Gene Testing and Diagnostics market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: CRISPR Gene Testing and Diagnostics revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global CRISPR Gene Testing and Diagnostics revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global CRISPR Gene Testing and Diagnostics market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including 10x Genomics, Aelian Biotechnology, Agilent Technologies, Axxam, Beckman Coulter, Becton, Dickinson and Company, Binx Health, bioMérieux and Bio-Rad Laboratories, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global CRISPR Gene Testing and Diagnostics Market Size 2017-2028
- 2.1.2 CRISPR Gene Testing and Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 CRISPR Gene Testing and Diagnostics Segment by Type
- 2.2.1 Animals
- 2.2.2 Plants
- 2.2.3 Pathogens
- 2.2.4 Others
- 2.3 CRISPR Gene Testing and Diagnostics Market Size by Type
- 2.3.1 CRISPR Gene Testing and Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global CRISPR Gene Testing and Diagnostics Market Size Market Share by Type (2017-2022)
- 2.4 CRISPR Gene Testing and Diagnostics Segment by Application
- 2.4.1 Medical Industry
- 2.4.2 Agriculture
- 2.4.3 Others
- 2.5 CRISPR Gene Testing and Diagnostics Market Size by Application
- 2.5.1 CRISPR Gene Testing and Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global CRISPR Gene Testing and Diagnostics Market Size Market Share by Application (2017-2022)
3 CRISPR Gene Testing and Diagnostics Market Size by Player
- 3.1 CRISPR Gene Testing and Diagnostics Market Size Market Share by Players
- 3.1.1 Global CRISPR Gene Testing and Diagnostics Revenue by Players (2020-2022)
- 3.1.2 Global CRISPR Gene Testing and Diagnostics Revenue Market Share by Players (2020-2022)
- 3.2 Global CRISPR Gene Testing and Diagnostics Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 CRISPR Gene Testing and Diagnostics by Regions
- 4.1 CRISPR Gene Testing and Diagnostics Market Size by Regions (2017-2022)
- 4.2 Americas CRISPR Gene Testing and Diagnostics Market Size Growth (2017-2022)
- 4.3 APAC CRISPR Gene Testing and Diagnostics Market Size Growth (2017-2022)
- 4.4 Europe CRISPR Gene Testing and Diagnostics Market Size Growth (2017-2022)
- 4.5 Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas CRISPR Gene Testing and Diagnostics Market Size by Country (2017-2022)
- 5.2 Americas CRISPR Gene Testing and Diagnostics Market Size by Type (2017-2022)
- 5.3 Americas CRISPR Gene Testing and Diagnostics Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC CRISPR Gene Testing and Diagnostics Market Size by Region (2017-2022)
- 6.2 APAC CRISPR Gene Testing and Diagnostics Market Size by Type (2017-2022)
- 6.3 APAC CRISPR Gene Testing and Diagnostics Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe CRISPR Gene Testing and Diagnostics by Country (2017-2022)
- 7.2 Europe CRISPR Gene Testing and Diagnostics Market Size by Type (2017-2022)
- 7.3 Europe CRISPR Gene Testing and Diagnostics Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa CRISPR Gene Testing and Diagnostics by Region (2017-2022)
- 8.2 Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size by Type (2017-2022)
- 8.3 Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global CRISPR Gene Testing and Diagnostics Market Forecast
- 10.1 Global CRISPR Gene Testing and Diagnostics Forecast by Regions (2023-2028)
- 10.1.1 Global CRISPR Gene Testing and Diagnostics Forecast by Regions (2023-2028)
- 10.1.2 Americas CRISPR Gene Testing and Diagnostics Forecast
- 10.1.3 APAC CRISPR Gene Testing and Diagnostics Forecast
- 10.1.4 Europe CRISPR Gene Testing and Diagnostics Forecast
- 10.1.5 Middle East & Africa CRISPR Gene Testing and Diagnostics Forecast
- 10.2 Americas CRISPR Gene Testing and Diagnostics Forecast by Country (2023-2028)
- 10.2.1 United States CRISPR Gene Testing and Diagnostics Market Forecast
- 10.2.2 Canada CRISPR Gene Testing and Diagnostics Market Forecast
- 10.2.3 Mexico CRISPR Gene Testing and Diagnostics Market Forecast
- 10.2.4 Brazil CRISPR Gene Testing and Diagnostics Market Forecast
- 10.3 APAC CRISPR Gene Testing and Diagnostics Forecast by Region (2023-2028)
- 10.3.1 China CRISPR Gene Testing and Diagnostics Market Forecast
- 10.3.2 Japan CRISPR Gene Testing and Diagnostics Market Forecast
- 10.3.3 Korea CRISPR Gene Testing and Diagnostics Market Forecast
- 10.3.4 Southeast Asia CRISPR Gene Testing and Diagnostics Market Forecast
- 10.3.5 India CRISPR Gene Testing and Diagnostics Market Forecast
- 10.3.6 Australia CRISPR Gene Testing and Diagnostics Market Forecast
- 10.4 Europe CRISPR Gene Testing and Diagnostics Forecast by Country (2023-2028)
- 10.4.1 Germany CRISPR Gene Testing and Diagnostics Market Forecast
- 10.4.2 France CRISPR Gene Testing and Diagnostics Market Forecast
- 10.4.3 UK CRISPR Gene Testing and Diagnostics Market Forecast
- 10.4.4 Italy CRISPR Gene Testing and Diagnostics Market Forecast
- 10.4.5 Russia CRISPR Gene Testing and Diagnostics Market Forecast
- 10.5 Middle East & Africa CRISPR Gene Testing and Diagnostics Forecast by Region (2023-2028)
- 10.5.1 Egypt CRISPR Gene Testing and Diagnostics Market Forecast
- 10.5.2 South Africa CRISPR Gene Testing and Diagnostics Market Forecast
- 10.5.3 Israel CRISPR Gene Testing and Diagnostics Market Forecast
- 10.5.4 Turkey CRISPR Gene Testing and Diagnostics Market Forecast
- 10.5.5 GCC Countries CRISPR Gene Testing and Diagnostics Market Forecast
- 10.6 Global CRISPR Gene Testing and Diagnostics Forecast by Type (2023-2028)
- 10.7 Global CRISPR Gene Testing and Diagnostics Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 10x Genomics
- 11.1.1 10x Genomics Company Information
- 11.1.2 10x Genomics CRISPR Gene Testing and Diagnostics Product Offered
- 11.1.3 10x Genomics CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 10x Genomics Main Business Overview
- 11.1.5 10x Genomics Latest Developments
- 11.2 Aelian Biotechnology
- 11.2.1 Aelian Biotechnology Company Information
- 11.2.2 Aelian Biotechnology CRISPR Gene Testing and Diagnostics Product Offered
- 11.2.3 Aelian Biotechnology CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Aelian Biotechnology Main Business Overview
- 11.2.5 Aelian Biotechnology Latest Developments
- 11.3 Agilent Technologies
- 11.3.1 Agilent Technologies Company Information
- 11.3.2 Agilent Technologies CRISPR Gene Testing and Diagnostics Product Offered
- 11.3.3 Agilent Technologies CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Agilent Technologies Main Business Overview
- 11.3.5 Agilent Technologies Latest Developments
- 11.4 Axxam
- 11.4.1 Axxam Company Information
- 11.4.2 Axxam CRISPR Gene Testing and Diagnostics Product Offered
- 11.4.3 Axxam CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Axxam Main Business Overview
- 11.4.5 Axxam Latest Developments
- 11.5 Beckman Coulter
- 11.5.1 Beckman Coulter Company Information
- 11.5.2 Beckman Coulter CRISPR Gene Testing and Diagnostics Product Offered
- 11.5.3 Beckman Coulter CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Beckman Coulter Main Business Overview
- 11.5.5 Beckman Coulter Latest Developments
- 11.6 Becton, Dickinson and Company
- 11.6.1 Becton, Dickinson and Company Company Information
- 11.6.2 Becton, Dickinson and Company CRISPR Gene Testing and Diagnostics Product Offered
- 11.6.3 Becton, Dickinson and Company CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Becton, Dickinson and Company Main Business Overview
- 11.6.5 Becton, Dickinson and Company Latest Developments
- 11.7 Binx Health
- 11.7.1 Binx Health Company Information
- 11.7.2 Binx Health CRISPR Gene Testing and Diagnostics Product Offered
- 11.7.3 Binx Health CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Binx Health Main Business Overview
- 11.7.5 Binx Health Latest Developments
- 11.8 bioMérieux
- 11.8.1 bioMérieux Company Information
- 11.8.2 bioMérieux CRISPR Gene Testing and Diagnostics Product Offered
- 11.8.3 bioMérieux CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 bioMérieux Main Business Overview
- 11.8.5 bioMérieux Latest Developments
- 11.9 Bio-Rad Laboratories
- 11.9.1 Bio-Rad Laboratories Company Information
- 11.9.2 Bio-Rad Laboratories CRISPR Gene Testing and Diagnostics Product Offered
- 11.9.3 Bio-Rad Laboratories CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Bio-Rad Laboratories Main Business Overview
- 11.9.5 Bio-Rad Laboratories Latest Developments
- 11.10 Caspr Biotech
- 11.10.1 Caspr Biotech Company Information
- 11.10.2 Caspr Biotech CRISPR Gene Testing and Diagnostics Product Offered
- 11.10.3 Caspr Biotech CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Caspr Biotech Main Business Overview
- 11.10.5 Caspr Biotech Latest Developments
- 11.11 ERS Genomics
- 11.11.1 ERS Genomics Company Information
- 11.11.2 ERS Genomics CRISPR Gene Testing and Diagnostics Product Offered
- 11.11.3 ERS Genomics CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 ERS Genomics Main Business Overview
- 11.11.5 ERS Genomics Latest Developments
- 11.12 FASMAC
- 11.12.1 FASMAC Company Information
- 11.12.2 FASMAC CRISPR Gene Testing and Diagnostics Product Offered
- 11.12.3 FASMAC CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 FASMAC Main Business Overview
- 11.12.5 FASMAC Latest Developments
- 11.13 Illumina
- 11.13.1 Illumina Company Information
- 11.13.2 Illumina CRISPR Gene Testing and Diagnostics Product Offered
- 11.13.3 Illumina CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 Illumina Main Business Overview
- 11.13.5 Illumina Latest Developments
- 11.14 Janssen Diagnostics
- 11.14.1 Janssen Diagnostics Company Information
- 11.14.2 Janssen Diagnostics CRISPR Gene Testing and Diagnostics Product Offered
- 11.14.3 Janssen Diagnostics CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.14.4 Janssen Diagnostics Main Business Overview
- 11.14.5 Janssen Diagnostics Latest Developments
- 11.15 Locus Biosciences
- 11.15.1 Locus Biosciences Company Information
- 11.15.2 Locus Biosciences CRISPR Gene Testing and Diagnostics Product Offered
- 11.15.3 Locus Biosciences CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.15.4 Locus Biosciences Main Business Overview
- 11.15.5 Locus Biosciences Latest Developments
- 11.16 Mammoth Biosciences
- 11.16.1 Mammoth Biosciences Company Information
- 11.16.2 Mammoth Biosciences CRISPR Gene Testing and Diagnostics Product Offered
- 11.16.3 Mammoth Biosciences CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.16.4 Mammoth Biosciences Main Business Overview
- 11.16.5 Mammoth Biosciences Latest Developments
- 11.17 NRGene
- 11.17.1 NRGene Company Information
- 11.17.2 NRGene CRISPR Gene Testing and Diagnostics Product Offered
- 11.17.3 NRGene CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.17.4 NRGene Main Business Overview
- 11.17.5 NRGene Latest Developments
- 11.18 Roche
- 11.18.1 Roche Company Information
- 11.18.2 Roche CRISPR Gene Testing and Diagnostics Product Offered
- 11.18.3 Roche CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.18.4 Roche Main Business Overview
- 11.18.5 Roche Latest Developments
- 11.19 Sherlock Biosciences
- 11.19.1 Sherlock Biosciences Company Information
- 11.19.2 Sherlock Biosciences CRISPR Gene Testing and Diagnostics Product Offered
- 11.19.3 Sherlock Biosciences CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.19.4 Sherlock Biosciences Main Business Overview
- 11.19.5 Sherlock Biosciences Latest Developments
- 11.20 Thermo Fisher Scientific
- 11.20.1 Thermo Fisher Scientific Company Information
- 11.20.2 Thermo Fisher Scientific CRISPR Gene Testing and Diagnostics Product Offered
- 11.20.3 Thermo Fisher Scientific CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.20.4 Thermo Fisher Scientific Main Business Overview
- 11.20.5 Thermo Fisher Scientific Latest Developments
- 11.21 Vivlion
- 11.21.1 Vivlion Company Information
- 11.21.2 Vivlion CRISPR Gene Testing and Diagnostics Product Offered
- 11.21.3 Vivlion CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.21.4 Vivlion Main Business Overview
- 11.21.5 Vivlion Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on CRISPR Gene Testing and Diagnostics. Industry analysis & Market Report on CRISPR Gene Testing and Diagnostics is a syndicated market report, published as Global CRISPR Gene Testing and Diagnostics Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of CRISPR Gene Testing and Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
